about
Pandemic influenza A (2009 H1N1) in children with acute lymphoblastic leukaemia.Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia.Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels.FLT3 is implicated in cytarabine transport by human equilibrative nucleoside transporter 1 in pediatric acute leukemia.Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood.Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study group.Outcomes and infectious etiologies of febrile neutropenia in non-immunocompromised children who present in an emergency department.Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.Novel and atypical splicing mutation in a compound heterozygous UNC13D defect presenting in Familial Hemophagocytic Lymphohistiocytosis triggered by EBV infection.Multiplex real-time PCR for prompt diagnosis of an outbreak of human parainfluenza 3 virus in children with acute leukemia.Prospective surveillance study of blood stream infections associated with central venous access devices (port-type) in children with acute leukemia: an intervention program.Epstein-Barr virus infection triggering a haemophagocytic syndrome.Successful port-a-cath salvage using linezolid in children with acute leukemia.RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia.[Self-monitoring treatment program with oral vitamin K antagonists in paediatric patients].Aplastic Crisis Secondary to Parvovirus B19 Infection as the First Manifestation of an Undiagnosed Hereditary Spherocytosis: Report of a Pediatric Series of Spanish Patients.Spuriously low pulse oximetry saturation associated with hemoglobin Sydney in a child and relatives: Identification of this unstable hemoglobin may avoid unnecessary testing and hospital admissions.Pediatric paraganglioma: An early manifestation of an adult disease secondary to germline mutationsGenetic analyses of aplastic anemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genesVery high hypertriglyceridemia induced: is plasmapheresis needed?Syndromic albinism and haemophagocytosisPaediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylasesDetectable clonal mosaicism in blood as a biomarker of cancer risk in Fanconi anemiaSuccessful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemiaAndrogen therapy in inherited bone marrow failure syndromes: analysis from the Canadian Inherited Marrow Failure RegistryPlatelet Dysfunction in Noonan and 22q11.2 Deletion Syndromes in ChildhoodLife-threatening secondary hemophagocytic lymphohistiocytosis following vagal nerve stimulator infection in a child with CHD2 myoclonic encephalopathy: a case reportOptimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studiesECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in SpainFMS-like tyrosine kinase 3 (FLT3) modulates key enzymes of nucleotide metabolism implicated in cytarabine responsiveness in pediatric acute leukemiaChromosome fragility in the buccal epithelium in patients with Fanconi anemiaMolecular analysis of the novel L243R mutation in STXBP2 reveals impairment of degranulation activitySynonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency
P50
Q30387338-B9594F5A-8913-46C1-8408-28DA2592AA87Q34797988-29D5D04F-401B-4C29-9CA5-DDFDEDD1B60BQ37510844-3C343788-CB07-47D1-AC4E-305F69B9A29FQ37580317-AE09387A-99B0-4DDA-9B25-12F06D1970CFQ37676271-74D58C87-20E5-4042-B7EA-465072AFAF51Q40109249-857568F5-0776-4475-A12C-D67C87ED1B80Q40693274-F92AFB8D-D1E0-49A4-87BB-C3F6B8A9F4A0Q41023406-69269428-E636-4CC8-B78C-22F97A34FAA7Q42215384-DDAD6AB3-1E8F-437E-8D6F-2D9F1CCFFEEFQ42256586-3D923A14-8BFD-4A66-B417-F6F151345E88Q42263867-A1227725-A8AA-4D5E-B3F3-3D925A4DF780Q43558265-AB5C626E-23D0-4EAD-89B2-E26DA5250EE3Q44089864-AB7C7988-8530-46D0-AD7A-E3B6BE3CDF8CQ47098092-50078E30-8A42-426A-8D7B-E0CE46B02C58Q50028629-F63631B3-9BBC-4632-9238-8F22C7EF45FEQ50936910-0C4A27E6-27CF-455D-B189-FB66733104C8Q54341675-ECF7387C-D247-454E-8308-3E457FC180C0Q60895657-C3982907-9072-4ECD-A820-3820A0001006Q64106199-8EECF15D-13AF-4F1E-A6AA-E50FAE62B9D6Q84207891-8884A713-02FD-4880-913C-82188FE95233Q84572717-D942C71F-2127-4180-A0DE-1C9B32AD6D41Q89441253-AD4AB8D4-ACB5-4D17-ADA7-601224A09448Q89777857-F28E8654-C0DC-4158-90AE-ABB7360E04CCQ90003769-E193EF0B-03ED-4313-A6C8-A597AB358681Q90020786-C0E1D8C0-F310-4A2C-BECB-9210BEA9FC2DQ90067843-24CEA30C-3819-4637-BF1D-F11085C16118Q90319026-A8A75D0E-CBA8-4085-9AD8-002A60200EADQ90509888-4D3B03CB-22CA-4A91-9E50-E6CE2AA1E5D7Q90623104-3C6D3896-F7F6-4394-A29D-6891DA80ACC2Q91510966-7C56FB0F-4C04-49A7-A347-1A5A3D2CED7BQ91921760-93473B83-8C7E-4961-B74A-79A3754DF2EEQ92179579-30E684CC-B8C2-4F42-AB5B-089EA3C110B1Q96576905-0DA7893A-A017-4DF9-9E87-10FF1985FA12
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Albert Catala
@ast
Albert Catala
@en
Albert Catala
@es
Albert Catala
@nl
type
label
Albert Catala
@ast
Albert Catala
@en
Albert Catala
@es
Albert Catala
@nl
prefLabel
Albert Catala
@ast
Albert Catala
@en
Albert Catala
@es
Albert Catala
@nl
P106
P21
P31
P496
0000-0003-0133-1752